Sitagliptin

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3820 publications

Fate of Trace Organic Contaminants in the Hyporheic Zone: A Laboratory-Scale Column Experiment.

Fate of Trace Organic Contaminants in the Hyporheic Zone: A Laboratory-Scale Column Experiment.

Journal: Environmental science & technology

Published: June 16, 2026

Correction to: Ertugliflozin improves animal behaviours associated with oxidative stress and inflammation in a BTBR T + Itpr3tf/J mouse model of autism.

Correction to: Ertugliflozin improves animal behaviours associated with oxidative stress and inflammation in a BTBR T + Itpr3tf/J mouse model of autism.

Journal: Brain communications

Published: June 08, 2026

Efficacy of pharmacological and nutritional interventions for glucose dysfunction in schizophrenia-A systematic review and network meta-analysis.

Efficacy of pharmacological and nutritional interventions for glucose dysfunction in schizophrenia-A systematic review and network meta-analysis.

Journal: Journal of psychopharmacology (Oxford, England)

Published: May 09, 2026

TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas.

TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: May 01, 2026

Quadruple Non-Insulin Therapy for Advanced Type 2 Diabetes Mellitus With Cognitive Impairment: A Case Report.

Quadruple Non-Insulin Therapy for Advanced Type 2 Diabetes Mellitus With Cognitive Impairment: A Case Report.

Journal: Cureus

Published: April 30, 2026

Repurposing doxycycline as an adjunct to sitagliptin in type 2 diabetes mellitus: a randomized controlled study on glycemic, inflammatory, and cardiometabolic outcomes.

Repurposing doxycycline as an adjunct to sitagliptin in type 2 diabetes mellitus: a randomized controlled study on glycemic, inflammatory, and cardiometabolic outcomes.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: April 21, 2026

Pharmacologic DPP-4 inhibition promotes CD8+ T cell metabolic fitness to enhance anti-tumor activity.

Pharmacologic DPP-4 inhibition promotes CD8+ T cell metabolic fitness to enhance anti-tumor activity.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Pharmacologic DPP-4 inhibition promotes CD8⁺ T cell metabolic fitness to enhance anti-tumor activity.

Pharmacologic DPP-4 inhibition promotes CD8⁺ T cell metabolic fitness to enhance anti-tumor activity.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Development and validation of an RP-HPLC method for simultaneous determination of sitagliptin and valsartan.

Development and validation of an RP-HPLC method for simultaneous determination of sitagliptin and valsartan.

Journal: Pakistan journal of pharmaceutical sciences

Published: April 04, 2026

ILK (Integrin-Linked Kinase)-Dependent Modulation of DPP4 (Dipeptidyl Peptidase 4) Prevents Progression of Calcific Aortic Valve Disease.

ILK (Integrin-Linked Kinase)-Dependent Modulation of DPP4 (Dipeptidyl Peptidase 4) Prevents Progression of Calcific Aortic Valve Disease.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: April 02, 2026

ILK-Dependent Modulation of DPP4 Prevents Progression of Calcific Aortic Valve Disease.

ILK-Dependent Modulation of DPP4 Prevents Progression of Calcific Aortic Valve Disease.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: April 02, 2026

TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas.

TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 30, 2026

Showing 1-12 of 3,820

Last Updated: 06/30/2026